HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eng H Lo Selected Research

Neuroglobin

1/2018Neuroglobin promotes neurogenesis through Wnt signaling pathway.
1/2016Establishment of Cell-Based Neuroglobin Promoter Reporter Assay for Neuroprotective Compounds Screening.
6/2012Neuroglobin-overexpression reduces traumatic brain lesion size in mice.
12/2011Neuroglobin is an endogenous neuroprotectant for retinal ganglion cells against glaucomatous damage.
3/2009Neuroprotective roles and mechanisms of neuroglobin.
1/2009Effects of neuroglobin overexpression on mitochondrial function and oxidative stress following hypoxia/reoxygenation in cultured neurons.
6/2008Effects of neuroglobin overexpression on acute brain injury and long-term outcomes after focal cerebral ischemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eng H Lo Research Topics

Disease

123Stroke (Strokes)
07/2023 - 03/2002
42Brain Ischemia (Cerebral Ischemia)
05/2024 - 03/2002
37Infarction (Infarctions)
01/2023 - 10/2005
37Ischemic Stroke
11/2021 - 03/2002
36Ischemia
05/2024 - 03/2002
26Brain Injuries (Brain Injury)
11/2021 - 05/2002
23Cerebral Hemorrhage
01/2021 - 03/2002
19Traumatic Brain Injuries (Traumatic Brain Injury)
11/2021 - 04/2002
19Hemorrhage
01/2021 - 03/2002
17Inflammation (Inflammations)
01/2022 - 07/2002
15Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
12/2022 - 12/2006
13Edema (Dropsy)
05/2024 - 11/2002
9Brain Edema (Cerebral Edema)
01/2023 - 05/2004
9Neuroinflammatory Diseases
01/2023 - 05/2009
9Wounds and Injuries (Trauma)
01/2022 - 04/2002
9Hypoxia (Hypoxemia)
10/2019 - 11/2003
9Embolic Stroke
12/2017 - 08/2002
8Cognitive Dysfunction
01/2022 - 02/2011
8Hyperglycemia
05/2019 - 02/2012
7Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
10/2021 - 12/2011
7Hematoma
01/2021 - 08/2011
6Brain Infarction
12/2018 - 06/2010
5Necrosis
01/2021 - 02/2005
5Reperfusion Injury
10/2020 - 11/2002
5Intracranial Hemorrhages (Intracranial Hemorrhage)
02/2013 - 03/2007
4Closed Head Injuries
01/2022 - 09/2014
4Hyperoxia
01/2020 - 04/2005
4Acidosis
01/2018 - 05/2008
3Neurologic Manifestations (Neurological Manifestations)
01/2022 - 06/2005
3Alzheimer Disease (Alzheimer's Disease)
01/2022 - 09/2006
3Brain Contusion
11/2021 - 09/2014
3Neuroblastoma
03/2019 - 04/2004
3Demyelinating Diseases (Demyelinating Disease)
11/2015 - 05/2012
2Carotid Stenosis (Carotid Artery Stenosis)
11/2023 - 01/2018
2Atrial Fibrillation
01/2023 - 01/2022
2Hypertension (High Blood Pressure)
01/2022 - 11/2019
2Hyperlipidemias (Hyperlipidemia)
01/2022 - 06/2018
2Cerebral Amyloid Angiopathy (Congophilic Angiopathy)
01/2022 - 08/2014

Drug/Important Bio-Agent (IBA)

28Matrix Metalloproteinases (MMPs)IBA
12/2017 - 03/2002
26Tissue Plasminogen Activator (Alteplase)FDA Link
12/2017 - 03/2002
23Biomarkers (Surrogate Marker)IBA
10/2022 - 02/2007
20Proteins (Proteins, Gene)FDA Link
05/2024 - 05/2002
17Matrix Metalloproteinase 9 (Gelatinase B)IBA
03/2013 - 11/2002
14Neuroprotective AgentsIBA
07/2023 - 04/2004
12Oxygen (Dioxygen)IBA
01/2021 - 03/2002
10Arachidonate 15-Lipoxygenase (Arachidonate 15 Lipoxygenase)IBA
01/2019 - 12/2006
10Warfarin (Coumadin)FDA LinkGeneric
01/2017 - 12/2008
9HMGB1 Protein (HMG1)IBA
08/2019 - 04/2010
9Hemoglobins (Hemoglobin)IBA
01/2017 - 03/2002
7Glucose (Dextrose)FDA LinkGeneric
01/2021 - 05/2008
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 04/2006
7NeuroglobinIBA
01/2018 - 06/2008
7Annexin A2 (Annexin II)IBA
12/2017 - 06/2010
7Collagenases (Collagenase)FDA Link
04/2015 - 05/2009
7Peptide Hydrolases (Proteases)FDA Link
12/2010 - 09/2004
6AnticoagulantsIBA
01/2023 - 08/2011
6Therapeutic UsesIBA
01/2023 - 01/2011
5Tight Junction ProteinsIBA
01/2023 - 09/2008
5GelatinIBA
01/2020 - 11/2002
5CytokinesIBA
12/2018 - 07/2009
5Protons (Proton)IBA
04/2018 - 05/2008
5AmidesIBA
04/2018 - 05/2008
4Fingolimod Hydrochloride (FTY720)FDA Link
12/2022 - 01/2011
4Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2022 - 06/2005
4Phosphotransferases (Kinase)IBA
11/2021 - 04/2002
4erucylphosphocholineIBA
08/2019 - 05/2012
4Conditioned Culture MediaIBA
01/2019 - 05/2008
4Matrix Metalloproteinase 2 (Gelatinase A)IBA
01/2018 - 05/2002
4Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
07/2017 - 12/2007
4Plasminogen Activators (Plasminogen Activator)IBA
01/2013 - 07/2002
4IntegrinsIBA
07/2010 - 07/2004
4Metalloproteases (Metalloproteinases)IBA
07/2009 - 01/2004
3histone deacetylase 3IBA
01/2023 - 05/2019
3AlbuminsIBA
01/2023 - 01/2007
3salicylhydroxamic acid (SHAM)IBA
01/2022 - 09/2014
3Amyloid (Amyloid Fibrils)IBA
01/2022 - 05/2008
3ChemokinesIBA
11/2021 - 07/2009
3IronIBA
10/2021 - 03/2015
3Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021 - 03/2015
3Free Radical ScavengersIBA
01/2020 - 01/2010
3fibroblast growth factor 21IBA
04/2019 - 06/2018
3APTIBA
01/2018 - 05/2008
3CaspasesIBA
01/2017 - 11/2003
3DabigatranFDA Link
05/2014 - 10/2011
3Minocycline (Cyclops)FDA LinkGeneric
03/2013 - 12/2008
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2012 - 11/2007
3GelatinasesIBA
05/2009 - 01/2004
3Matrix Metalloproteinase InhibitorsIBA
04/2006 - 03/2002
3Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
04/2004 - 04/2002
2Small Interfering RNA (siRNA)IBA
05/2024 - 01/2021
2CalciumIBA
12/2023 - 08/2019
2Evans Blue (Blue, Evans)FDA Link
01/2023 - 07/2012
2fluorocitrateIBA
01/2023 - 04/2010
2Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2023 - 07/2017
2RGFP966IBA
01/2023 - 10/2020
2Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
01/2022 - 01/2019

Therapy/Procedure

67Therapeutics
10/2022 - 03/2002
12Thrombolytic Therapy
01/2014 - 03/2002
3Ischemic Postconditioning
01/2023 - 09/2015
3Anticoagulation Reversal
04/2012 - 05/2009